Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Autologous human adipose tissue derived bone tissue therapy - Bonus BioGroup

Next Previous
Drug Profile

Autologous human adipose tissue derived bone tissue therapy - Bonus BioGroup

Alternative Names: Bone graft for maxillofacial applications - Bonus BioGroup; BonoFill; BonoFill-II; HATDCs - Bonus BioGroup; Human Adipose Tissue Derived Cells - Bonus BioGroup

Latest Information Update: 16 Jul 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bonus BioGroup
  • Class Mesenchymal stem cell therapies; Tissue transplantation therapies
  • Mechanism of Action Tissue replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Bone disorders

Most Recent Events

  • 14 Jul 2025 Bonus BioGroup plans a phase III trial in Bone disorder in 2026
  • 23 Mar 2017 Phase-I/II development for Bone disorders (maxillofacial) is ongoing in Israel (Implant)
  • 24 Jan 2017 BonusBio Group plans a phase I/II trial for Bone disorders in Israel (NCT03024008)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top